Overview
Prototype with real wet‑lab validation and 12‑expert review; promising for lab design workflows but needs broader external validation and integration before clinical or high‑throughput deployment.
Citations9
Evidence Strength0.70
Confidence0.85
Risk Signals11
Trust Signals
Findings with numeric evidence: 4/4
Findings with evidence refs: 4/4
Results with explicit delta: 1/3
Reproducibility
Status: No open assets linked
Open source: Unknown
At A Glance
Cost impact: 60%
Production readiness: 60%
Novelty: 70%
Why It Matters For Business
Automating CRISPR design reduces expert time, speeds prototyping, and lowers error risk in early‑stage research; it can cut planning cycles and standardize lab protocols for teams without CRISPR specialists.
Who Should Care
Summary TLDR
CRISPR-GPT is an LLM-powered agent that combines a planner, a tool wrapper, and state‑machine task executors to automate CRISPR experiment design. It supports 22 task states (4 meta‑pipelines), calls tools such as Primer3 and guide libraries, includes safety filters (e.g., blocks >=20 bp sequences and warns on human targets), received higher expert ratings than base ChatGPT in design tasks, and helped non-experts run a 4‑gene knockout in A375 cells with successful NGS validation. The system is a prototype: useful for design automation but not a replacement for wet‑lab expertise or clinical use.
Problem Statement
General LLMs produce confident but sometimes incorrect or incomplete guidance for CRISPR experiments (wrong guides, missing protocol details, unsafe suggestions). Researchers need a domain-aware agent that integrates tools and checks to produce practical, verifiable experimental designs for beginners and non-experts.
Main Contribution
An agent architecture combining an LLM planner, a Tool Provider wrapper, and state‑machine Task Executor to break CRISPR workflows into subgoals.
Implementation of 22 task states across 4 predefined meta‑pipelines (knockout, base editing, prime editing, activation/repression) and 13 Auto‑Mode tasks.
Key Findings
Domain‑augmented agent scored higher than general ChatGPT on expert design ratings.
CRISPR‑GPT executed a real knockout workflow and produced validation‑ready results.
Results
| Metric | Value | Baseline | Delta | Split / Dataset | Evidence | Evidence Ref |
|---|---|---|---|---|---|---|
| Accuracy | CRISPR‑GPT scored higher than ChatGPT 3.5 and ChatGPT 4 in expert ratings (1–5 scale) | ChatGPT 3.5 / ChatGPT 4 | Higher mean scores across metrics (Figure 6) | 12 CRISPR experts, multiple design tasks | Section 2.2 and Figure 6 | Figure 6 |
| Wet‑lab validation — editing outcome | Consistent high rate of expected edits across 4 targeted genes by NGS | — | — | A375 cell line; targets: TGFBR1, SNAI1, BAX, BCL2L1 | Section 3.3 and Figure 7 | Figure 7 |
What To Try In 7 Days
Run Auto Mode to design an sgRNA knockout for a non‑clinical cell line and compare with your current design workflow
Integrate Primer3 calls into your pipeline to auto‑generate and BLAST‑check PCR primers
Set up the ≥20 bp input filter and human‑target warning flow to test privacy and safety gates
Agent Features
Memory
Planning
Tool Use
Frameworks
Is Agentic
Yes
Architectures
Collaboration
Reproducibility
Risks & Boundaries
Limitations
Cannot generate complete DNA constructs or vectors from natural language inputs.
Performance degrades on rare or complex biological cases and needs up‑to‑date domain data.
When Not To Use
Clinical decision‑making or patient care without expert oversight
Designs for human germline or embryo editing (legal/ethical restrictions apply)
Failure Modes
Proposed sgRNA sequences that do not align to the target genome if external checks are skipped
Incomplete protocols missing reagent quantities or timing details in edge cases